Billionaire Bill Ackman Sells Disastrous Valeant Investment After ...
Mar 13, 2017 · Billionaire Bill Ackman has exited one of the most disastrous hedge fund investments ever, selling his hedge fund’s remaining shares in Valeant Pharmaceuticals. Ackman gave up on Valeant...
A Buried Scandal, Shedding Of Assets, And Forthcoming Spinoff ... - Forbes
Apr 28, 2021 · Having a troubled past under the name Valeant, Bausch Health Companies (BHC) saw its leverage balloon.
Inside the Valeant Scandal - The New Yorker
Mar 28, 2016 · The influential hedge-fund manager Bill Ackman, one of Valeant’s largest shareholders, compared Pearson to Warren Buffett, citing his genius at capital allocation.
A Brief Timeline Of The Bill Ackman-Valeant Relationship - Yahoo Finance
After a headline-filled tenure, Bill Ackman's investment in Valeant Pharmaceuticals Intl Inc (NYSE: VRX ) is over. As first reported by CNBC and TheStreet, and later confirmed to Benzinga ,...
Bill Ackman - Wikipedia
Ackman opened his testimony saying, "As a shareholder of Valeant, I recognize my investment was an... endorsement of Valeant's strategy." [ 26 ] Ackman sold his remaining 27.2 million share position in Valeant to the investment bank Jefferies for about $300 million in March 2017.
Bill Ackman apologises for “huge” Valeant mistake - Financial Times
Mar 29, 2017 · When Bill Ackman sold what remained of his disastrous investment in Valeant Pharmaceuticals earlier this month, he said it was because it was taking up too much of his time and too much of his...
Bill Ackman bails on his massive, money-losing bet on Valeant
Mar 13, 2017 · Activist investor Bill Ackman, the CEO of $11 billion Pershing Square Capital, has exited his massive, money-losing bet in Valeant Pharmaceuticals.
Ackman ditches disastrous Valeant investment - Financial Times
Mar 13, 2017 · Bill Ackman’s Pershing Square has sold its 5.3 per cent stake in Valeant Pharmaceuticals, bringing down the curtain on one of the most disastrous investments in the hedge fund’s history.
Bill Ackman Sells Valeant Stake After $2.8 Billion Loss
Mar.14 -- Bill Ackman has sold his entire stake in Valeant Pharmaceuticals International Inc. and will leave the board after his Pershing Square Capital Management lost at least $2.8 billion....
How to Lose $4 Billion: Bill Ackman's Long Ride Down on Valeant
Mar 15, 2017 · How to Lose $4 Billion: Bill Ackman's Long Ride Down on Valeant. Ackman reiterated confidence in company just two weeks ago; Investment in drugmaker was sucking up time, resources